Skip to main content
TipRanks
Go Ultimate75% OFF

Robert Rosiello Insider Profile

11 Followers

Robert Rosiello, Director at Seres Therapeutics, holds ― shares in Seres Therapeutics (Ticker: MCRB), holds 449.55K shares in Bausch Health Companies (Ticker: BHC), holds ― shares in Evelo Biosciences (Ticker: EVLO).

Robert Rosiello's Trading History

BHC
Bausch Health Companies
Dec 07, 2016EVP & CFOUninformative Sell264.37K$3.75M
OMGAQ
Omega Therapeutics
――――
SANA
Sana Biotechnology
―Director――
AXLA
Axcella Health
――――
EVLO
Evelo Biosciences
―Director――
MCRB
Seres Therapeutics
―Director――

You May Also Like

Robert Rosiello insider profile FAQ

What is the percentage of profitable transactions made by Robert Rosiello?
The percentage of profitable transactions made by Robert Rosiello is 0%.
What is the average return per transaction made by Robert Rosiello?
The average return per transaction made by Robert Rosiello is -90.70%.
What stocks does Robert Rosiello hold?
Robert Rosiello holds: MCRB, BHC, EVLO, AXLA, SANA, OMGAQ stocks.
What was Robert Rosiello's most profitable transaction?
Robert Rosiello’s most profitable transaction was an Informative Buy of BHC stock on June 16, 2015. The return on the trade was -90.10%.
What is Robert Rosiello's role in Seres Therapeutics?
Robert Rosiello's role in Seres Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.